Publication | Closed Access

Targeted delivery of celastrol to renal interstitial myofibroblasts using fibronectin-binding liposomes attenuates renal fibrosis and reduces systemic toxicity

Cell-based Drug DeliveryNanomedicineFibrosisEngineeringFibronectin-binding LiposomesPathologyRenal FibrosisExtracellular MicrovesiclesReduces Systemic ToxicityBiomedical EngineeringMatrix BiologyMedicineCell BiologyTumor MicroenvironmentExtracellular Matrix